• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多参数磁共振成像对评估非酒精性脂肪性肝病的疾病严重程度具有重要价值。

Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease.

机构信息

Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.

Bundang Jesaeng General Hospital, Hepatology Center.

出版信息

Clin Transl Gastroenterol. 2020 Apr;11(4):e00157. doi: 10.14309/ctg.0000000000000157.

DOI:10.14309/ctg.0000000000000157
PMID:32251018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7263657/
Abstract

INTRODUCTION

Because nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of chronic liver disease, noninvasive evaluations of its severity are immediately needed. This prospective cross-sectional study evaluated the effectiveness of noninvasive assessments of hepatic steatosis, fibrosis, and steatohepatitis.

METHODS

Patients underwent laboratory tests, liver biopsy, transient elastography, and MRI. Multiparametric MR was used to measure MRI proton density fat fraction, MR spectroscopy, T1 mapping, and MR elastography (MRE).

RESULTS

We enrolled 130 patients between October 2016 and July 2019. For the diagnosis of moderate-to-severe steatosis (grade ≥ 2), the area under the receiver operating characteristic curve (AUROC) was lower in controlled attenuation parameter (0.69; 95% confidence interval [CI], 0.60-0.76) than MRI proton density fat fraction (0.82; 95% CI, 0.75-0.89; P = 0.008) and MR spectroscopy (0.83; 95% CI, 0.75-0.89; P = 0.006). For the diagnosis of advanced fibrosis (stage ≥ 3), the AUROC of MRE (0.89; 95% CI, 0.83-0.94) was superior compared with those of the Fibrosis-4 index (0.77; 95% CI, 0.69-0.84; P = 0.010), NAFLD fibrosis score (0.81; 95% CI, 0.73-0.87; P = 0.043), and transient elastography (0.82; 95% CI, 0.74-0.88; P = 0.062). For detecting advanced fibrosis or nonalcoholic steatohepatitis, the AUROC of MRE (0.86; 95% CI, 0.79-0.91) was higher than that of TE (0.76; 95% CI, 0.68-0.83) with statistical significance (P = 0.018).

DISCUSSION

Multiparametric MR accurately identified a severe form of NAFLD. Multiparametric MR can be a valuable noninvasive method for evaluating the severity of NAFLD.

摘要

简介

由于非酒精性脂肪性肝病(NAFLD)正在成为慢性肝病的主要病因,因此急需对其严重程度进行非侵入性评估。本前瞻性横断面研究评估了肝脂肪变性、纤维化和脂肪性肝炎的非侵入性评估的有效性。

方法

患者接受了实验室检查、肝活检、瞬时弹性成像和 MRI 检查。多参数 MRI 用于测量 MRI 质子密度脂肪分数、磁共振波谱、T1 映射和 MRI 弹性成像(MRE)。

结果

我们于 2016 年 10 月至 2019 年 7 月期间纳入了 130 名患者。对于中重度脂肪变性(等级≥2)的诊断,受控衰减参数的受试者工作特征曲线下面积(AUROC)低于 MRI 质子密度脂肪分数(0.82;95%置信区间 [CI],0.75-0.89;P=0.008)和磁共振波谱(0.83;95%CI,0.75-0.89;P=0.006)。对于晚期纤维化(分期≥3)的诊断,MRE 的 AUROC(0.89;95%CI,0.83-0.94)优于 Fibrosis-4 指数(0.77;95%CI,0.69-0.84;P=0.010)、NAFLD 纤维化评分(0.81;95%CI,0.73-0.87;P=0.043)和瞬时弹性成像(0.82;95%CI,0.74-0.88;P=0.062)。对于检测晚期纤维化或非酒精性脂肪性肝炎,MRE 的 AUROC(0.86;95%CI,0.79-0.91)高于 TE 的 AUROC(0.76;95%CI,0.68-0.83),差异有统计学意义(P=0.018)。

讨论

多参数 MRI 能准确识别严重的 NAFLD 形式。多参数 MRI 可能是评估 NAFLD 严重程度的一种有价值的非侵入性方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/392ccffc6993/ct9-11-e00157-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/7968e832e132/ct9-11-e00157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/6576591701c1/ct9-11-e00157-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/392ccffc6993/ct9-11-e00157-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/7968e832e132/ct9-11-e00157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/6576591701c1/ct9-11-e00157-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae35/7263657/392ccffc6993/ct9-11-e00157-g008.jpg

相似文献

1
Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease.多参数磁共振成像对评估非酒精性脂肪性肝病的疾病严重程度具有重要价值。
Clin Transl Gastroenterol. 2020 Apr;11(4):e00157. doi: 10.14309/ctg.0000000000000157.
2
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.磁共振弹性成像与瞬时弹性成像在经活检证实的非酒精性脂肪性肝病患者纤维化检测及脂肪变性无创测量中的比较
Gastroenterology. 2017 Feb;152(3):598-607.e2. doi: 10.1053/j.gastro.2016.10.026. Epub 2016 Oct 27.
3
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.磁共振成像比瞬时弹性成像更能准确地对非酒精性脂肪性肝病患者的脂肪变性和纤维化进行分类。
Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.
4
The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.磁共振弹性成像联合质子密度脂肪分数对非酒精性脂肪性肝炎的诊断价值。
J Magn Reson Imaging. 2022 Aug;56(2):368-379. doi: 10.1002/jmri.28040. Epub 2021 Dec 25.
5
Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.非酒精性脂肪性肝病中肝活检与影像学方法的评估:阿姆斯特丹非酒精性脂肪性肝病-非酒精性脂肪性肝炎队列。
J Magn Reson Imaging. 2021 Dec;54(6):1937-1949. doi: 10.1002/jmri.27703. Epub 2021 May 15.
6
Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.多参数磁共振指数在非酒精性脂肪性肝病患者非酒精性肝炎诊断中的应用。
Sci Rep. 2020 Feb 14;10(1):2671. doi: 10.1038/s41598-020-59601-3.
7
MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.磁共振弹性成像可有效用于非酒精性脂肪性肝病患者肝纤维化和坏死性炎症活动的无创评估。
Eur J Radiol. 2018 Jan;98:82-89. doi: 10.1016/j.ejrad.2017.11.003. Epub 2017 Nov 11.
8
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.振动控制瞬时弹性成像评估非酒精性脂肪性肝病患者的纤维化和脂肪变性。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):156-163.e2. doi: 10.1016/j.cgh.2018.04.043. Epub 2018 Apr 26.
9
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.定量多参数磁共振成像有助于日本队列中的非酒精性脂肪性肝炎诊断。
World J Gastroenterol. 2021 Feb 21;27(7):609-623. doi: 10.3748/wjg.v27.i7.609.
10
Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.二维剪切波弹性成像、瞬时弹性成像和磁共振弹性成像在诊断非酒精性脂肪性肝病患者纤维化中的比较。
AJR Am J Roentgenol. 2020 Jan;214(1):W20-W26. doi: 10.2214/AJR.19.21267. Epub 2019 Nov 12.

引用本文的文献

1
Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.非侵入性成像技术对代谢相关脂肪性肝病(MASLD)患者诊断代谢相关脂肪性肝炎(MASH)的准确性:一项系统评价
Liver Int. 2025 Apr;45(4):e16127. doi: 10.1111/liv.16127. Epub 2024 Oct 14.
2
Sex-specific associations in multiparametric 3 T MRI measurements in adult livers.多参数 3T MRI 测量在成人肝脏中的性别特异性关联。
Abdom Radiol (NY). 2023 Oct;48(10):3072-3078. doi: 10.1007/s00261-023-03981-3. Epub 2023 Jun 28.
3
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.

本文引用的文献

1
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏疾病的无创评估。
Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18.
2
Recent research trends and updates on nonalcoholic fatty liver disease.非酒精性脂肪性肝病的最新研究趋势和进展。
Clin Mol Hepatol. 2019 Mar;25(1):1-11. doi: 10.3350/cmh.2018.0037. Epub 2018 Aug 8.
3
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
应用磁共振弹性成像对非酒精性脂肪性肝病纤维化分期的截止值和混杂因素进行个体患者数据的荟萃分析。
J Hepatol. 2023 Sep;79(3):592-604. doi: 10.1016/j.jhep.2023.04.025. Epub 2023 Apr 29.
4
Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population.对平均风险人群中晚期纤维化的纤维化-4指数和非酒精性脂肪性肝病纤维化评分的重新评估。
Front Med (Lausanne). 2022 Nov 3;9:1024836. doi: 10.3389/fmed.2022.1024836. eCollection 2022.
5
Non-alcoholic fatty liver disease: A patient guideline.非酒精性脂肪性肝病:患者指南。
JHEP Rep. 2021 Sep 17;3(5):100322. doi: 10.1016/j.jhepr.2021.100322. eCollection 2021 Oct.
6
Screening for nonalcoholic fatty liver disease-when, who and how?非酒精性脂肪性肝病筛查:何时、谁以及如何进行?
World J Gastroenterol. 2021 Sep 21;27(35):5803-5821. doi: 10.3748/wjg.v27.i35.5803.
7
Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression.通过分析血清外泌体 miRNA 表达评价非酒精性脂肪性肝病的严重程度。
PLoS One. 2021 Aug 6;16(8):e0255822. doi: 10.1371/journal.pone.0255822. eCollection 2021.
8
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease.循环 miRNA 是一种用于非酒精性脂肪性肝病中非酒精性肝炎的有用的诊断生物标志物。
Sci Rep. 2021 Jul 19;11(1):14639. doi: 10.1038/s41598-021-94115-6.
9
Multiparametric MR mapping in clinical decision-making for diffuse liver disease.多参数磁共振成像在弥漫性肝病临床决策中的应用
Abdom Radiol (NY). 2020 Nov;45(11):3507-3522. doi: 10.1007/s00261-020-02684-3. Epub 2020 Aug 5.
10
Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study.超重儿科患者肝脂肪变性的特征是血浆转化生长因子 β(TGF-β)水平升高和全身性生化紊乱程度增加:一项横断面研究。
Nutrients. 2020 Jun 2;12(6):1650. doi: 10.3390/nu12061650.
磁共振与瞬时弹性成像分析非酒精性脂肪性肝病患者:系统评价和个体参与者汇总分析。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):630-637.e8. doi: 10.1016/j.cgh.2018.05.059. Epub 2018 Jun 14.
4
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的无创性生物标志物:当前进展与未来前景。
Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):461-478. doi: 10.1038/s41575-018-0014-9.
5
Evaluation of 2-point, 3-point, and 6-point Dixon magnetic resonance imaging with flexible echo timing for muscle fat quantification.两点、三点和六点 Dixon 磁共振成像的评估,采用灵活回波时间进行肌肉脂肪定量分析。
Eur J Radiol. 2018 Jun;103:57-64. doi: 10.1016/j.ejrad.2018.04.011. Epub 2018 Apr 12.
6
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?弹性成像能否区分单纯性脂肪肝与非酒精性脂肪性肝炎?
Semin Liver Dis. 2018 Feb;38(1):14-20. doi: 10.1055/s-0037-1618587. Epub 2018 Feb 22.
7
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD.NAFLD 患者肝纤维化的弹性成像无创影像学生物标志物评估。
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):274-282. doi: 10.1038/nrgastro.2018.10. Epub 2018 Feb 21.
8
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.MRI-PDFF 无创定量评估肝脂肪作为 NASH 试验的终点。
Hepatology. 2018 Aug;68(2):763-772. doi: 10.1002/hep.29797.
9
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.多参数磁共振成像在非酒精性脂肪性肝病评估中的效用和成本评估。
Aliment Pharmacol Ther. 2018 Mar;47(5):631-644. doi: 10.1111/apt.14469. Epub 2017 Dec 22.
10
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理:美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.